A Synthetic C34 Trimer of HIV‐1 gp41 Shows Significant Increase in Inhibition Potency

This publication has 36 references indexed in Scilit:

• Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
  Proceedings of the National Academy of Sciences, 2010
• Remodeling of Dynamic Structures of HIV-1 Envelope Proteins Leads to Synthetic Antigen Molecules Inducing Neutralizing Antibodies
  Bioconjugate Chemistry, 2010
• Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding
  PLOS Pathogens, 2009
• A Template‐assembled Model of the N‐peptide Helix Bundle from HIV‐1 Gp‐41 with High Affinity for C‐peptide
  Chemical Biology & Drug Design, 2007
• The Stability of the Intact Envelope Glycoproteins is a Major Determinant of Sensitivity of HIV/SIV to Peptidic Fusion Inhibitors
  Journal of Molecular Biology, 2004
• Novel Therapies Based on Mechanisms of HIV-1 Cell Entry
  New England Journal of Medicine, 2003
• CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
  Annual Review of Immunology, 1999
• HIV-1 Membrane Fusion Mechanism: Structural Studies of the Interactions between Biologically-Active Peptides from gp41
  Biochemistry, 1996
• Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
  Proceedings of the National Academy of Sciences, 1994
• HIV-1 inhibition by a peptide
  Nature, 1993